Common Myeloid Progenitors

David Traver, Koichi Akashi

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

This chapter presents a brief history of hematopoietic stem and progenitor cell biology, emphasizing commitment to the myeloerythroid fates. It also describes the cell surface profiles of recently identified stem and progenitor cell subsets in both mice and humans, and explains potential therapeutic applications of committed progenitor cells. Hematopoiesis is initiated by rare hematopoietic stem cells (HSCs) that maintain production of blood cells for life. This astounding production is the result of mitotic amplification of the lineage-committed progenitor cells that are the daughters of HSCs. Although the existence of lineage-restricted hematopoietic progenitors has been postulated for many years, the ability to prospective isolate HSCs paved the way for the phenotypic discovery of lineage-restricted progenitors downstream of HSCs, such as common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs), which can be similarly isolated by cell surface characteristics. The modern era of HSC biology began with the first rigorous, prospective isolation of murine HSCs by cell surface phenotype. Investigators showed that long-term, multilineage reconstitution activity was present only within a population of Lin /loThy1.1loSca-1+ bone marrow cells.

Original languageEnglish
Title of host publicationAdult and Fetal
PublisherElsevier Inc.
Pages355-376
Number of pages22
Volume2
ISBN (Electronic)9780080533735
ISBN (Print)9780124366435
DOIs
Publication statusPublished - Sep 14 2004

Fingerprint

Myeloid Progenitor Cells
Hematopoietic Stem Cells
Stem cells
Cytology
Stem Cells
Cells
Cell Biology
Lymphoid Progenitor Cells
Amplification
Hematopoiesis
Bone
Blood
Bone Marrow Cells
Blood Cells
Research Personnel
Phenotype

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Traver, D., & Akashi, K. (2004). Common Myeloid Progenitors. In Adult and Fetal (Vol. 2, pp. 355-376). Elsevier Inc.. https://doi.org/10.1016/B978-012436643-5/50124-3

Common Myeloid Progenitors. / Traver, David; Akashi, Koichi.

Adult and Fetal. Vol. 2 Elsevier Inc., 2004. p. 355-376.

Research output: Chapter in Book/Report/Conference proceedingChapter

Traver, D & Akashi, K 2004, Common Myeloid Progenitors. in Adult and Fetal. vol. 2, Elsevier Inc., pp. 355-376. https://doi.org/10.1016/B978-012436643-5/50124-3
Traver D, Akashi K. Common Myeloid Progenitors. In Adult and Fetal. Vol. 2. Elsevier Inc. 2004. p. 355-376 https://doi.org/10.1016/B978-012436643-5/50124-3
Traver, David ; Akashi, Koichi. / Common Myeloid Progenitors. Adult and Fetal. Vol. 2 Elsevier Inc., 2004. pp. 355-376
@inbook{da5b5da8ffb54480807e884fd849b1da,
title = "Common Myeloid Progenitors",
abstract = "This chapter presents a brief history of hematopoietic stem and progenitor cell biology, emphasizing commitment to the myeloerythroid fates. It also describes the cell surface profiles of recently identified stem and progenitor cell subsets in both mice and humans, and explains potential therapeutic applications of committed progenitor cells. Hematopoiesis is initiated by rare hematopoietic stem cells (HSCs) that maintain production of blood cells for life. This astounding production is the result of mitotic amplification of the lineage-committed progenitor cells that are the daughters of HSCs. Although the existence of lineage-restricted hematopoietic progenitors has been postulated for many years, the ability to prospective isolate HSCs paved the way for the phenotypic discovery of lineage-restricted progenitors downstream of HSCs, such as common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs), which can be similarly isolated by cell surface characteristics. The modern era of HSC biology began with the first rigorous, prospective isolation of murine HSCs by cell surface phenotype. Investigators showed that long-term, multilineage reconstitution activity was present only within a population of Lin /loThy1.1loSca-1+ bone marrow cells.",
author = "David Traver and Koichi Akashi",
year = "2004",
month = "9",
day = "14",
doi = "10.1016/B978-012436643-5/50124-3",
language = "English",
isbn = "9780124366435",
volume = "2",
pages = "355--376",
booktitle = "Adult and Fetal",
publisher = "Elsevier Inc.",
address = "United States",

}

TY - CHAP

T1 - Common Myeloid Progenitors

AU - Traver, David

AU - Akashi, Koichi

PY - 2004/9/14

Y1 - 2004/9/14

N2 - This chapter presents a brief history of hematopoietic stem and progenitor cell biology, emphasizing commitment to the myeloerythroid fates. It also describes the cell surface profiles of recently identified stem and progenitor cell subsets in both mice and humans, and explains potential therapeutic applications of committed progenitor cells. Hematopoiesis is initiated by rare hematopoietic stem cells (HSCs) that maintain production of blood cells for life. This astounding production is the result of mitotic amplification of the lineage-committed progenitor cells that are the daughters of HSCs. Although the existence of lineage-restricted hematopoietic progenitors has been postulated for many years, the ability to prospective isolate HSCs paved the way for the phenotypic discovery of lineage-restricted progenitors downstream of HSCs, such as common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs), which can be similarly isolated by cell surface characteristics. The modern era of HSC biology began with the first rigorous, prospective isolation of murine HSCs by cell surface phenotype. Investigators showed that long-term, multilineage reconstitution activity was present only within a population of Lin /loThy1.1loSca-1+ bone marrow cells.

AB - This chapter presents a brief history of hematopoietic stem and progenitor cell biology, emphasizing commitment to the myeloerythroid fates. It also describes the cell surface profiles of recently identified stem and progenitor cell subsets in both mice and humans, and explains potential therapeutic applications of committed progenitor cells. Hematopoiesis is initiated by rare hematopoietic stem cells (HSCs) that maintain production of blood cells for life. This astounding production is the result of mitotic amplification of the lineage-committed progenitor cells that are the daughters of HSCs. Although the existence of lineage-restricted hematopoietic progenitors has been postulated for many years, the ability to prospective isolate HSCs paved the way for the phenotypic discovery of lineage-restricted progenitors downstream of HSCs, such as common lymphoid progenitors (CLPs) and common myeloid progenitors (CMPs), which can be similarly isolated by cell surface characteristics. The modern era of HSC biology began with the first rigorous, prospective isolation of murine HSCs by cell surface phenotype. Investigators showed that long-term, multilineage reconstitution activity was present only within a population of Lin /loThy1.1loSca-1+ bone marrow cells.

UR - http://www.scopus.com/inward/record.url?scp=58549098822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549098822&partnerID=8YFLogxK

U2 - 10.1016/B978-012436643-5/50124-3

DO - 10.1016/B978-012436643-5/50124-3

M3 - Chapter

SN - 9780124366435

VL - 2

SP - 355

EP - 376

BT - Adult and Fetal

PB - Elsevier Inc.

ER -